Results 31 to 40 of about 370,495 (313)

LDL protein nitration: Implication for LDL protein unfolding [PDF]

Archives of Biochemistry and Biophysics, 2008
Oxidatively- or enzymatically-modified low-density lipoprotein (LDL) is intimately involved in the initiation and progression of atherosclerosis. The in vivo modified LDL is electro-negative (LDL(-)) and consists of peroxidized lipid and unfolded apoB-100 protein.
Ryan T, Hamilton, Liana, Asatryan, Jon T, Nilsen, Jose M, Isas, Timothy K, Gallaher, Tatsuya, Sawamura, Tzung K, Hsiai   +6 more
openaire   +2 more sources

LDL-C response by 6-month treatment of statin or statin + ezetimibe.

, 2023
LDL-C response by 6-month treatment of statin or statin + ezetimibe.
Joo-Hee Zo (721373), Jae-Bin Seo (721370), Myung-A Kim (721372), Woo-Hyun Lim (6157328), Hack-Lyoung Kim (654343), Sang-Hyun Kim (282188)   +5 more
core   +1 more source

CORRELATION BETWEEN APOPROTEIN B/APOPROTEIN A-I RATIO WITH HOMA IR VALUE (HOMEOSTATIC MODEL ASSESMENT INSULIN RESISTANCE) IN TYPE 2 DIABETES MELLITUS

Journal of Vocational Health Studies, 2019
Background: Diabetes mellitus (DM) is the seventh leading cause of death in the world (the occuring rate has reached 400 million people). Type2 DM is caused by the body cells’ inability to respond normally to insulin (insulin resistance).
Muhammad Rafli Afandi, Ferdy Royland Marpaung   +1 more
doaj   +1 more source

Correlation between Serum Caspase-1, IL-10, HOMA-IR, FAI, Dyslipidemia, and Oxidative Stress Status in Women with Polycystic Ovary Syndrome

Journal of Pharmacy and Bioallied Sciences
Introduction: Polycystic ovary syndrome (PCOS) is a common endocrinopathy characterized by hyperandrogenism, insulin resistance, and dyslipidemia. Inflammation and oxidative stress play critical roles in its pathogenesis.
Neelam Gusain, Ashish Anjankar, Ranjit Ambad   +2 more
doaj   +1 more source

Up-regulated miR-106b inhibits ox-LDL-induced endothelial cell apoptosis in atherosclerosis

, 2020
This research aimed to explore the molecular mechanism of microRNA (miR)-106b in cell apoptosis of atherosclerosis (AS). Human aortic endothelial cells (HAECs) were divided into control group, oxidized-low-density lipoproteins (ox-LDL) group, miR-106b NC+
Jie Xu (34477), Xiaomei Kong (8527719), Yunqing Zhang (300080), Lin Zou (445129), Li Wang (15202)   +4 more
core   +1 more source

A correlative study of uric acid with lipid profile

Asian Journal of Medical Sciences, 2013
Objective: the study was conducted to verify the association of hyperuricemia with lipid profile in a group of Assamese people so as to take necessary precautions from developing future cardiovascular disease (CVD).
Devajit Sarmah
doaj   +1 more source

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study) [PDF]

Endocrinology and Metabolism, 2020
Background While randomized controlled trials provide useful information about drug safety and efficacy, they do not always reflect the observed results in the real world.
In-Kyung Jeong, Sung-Rae Kim
doaj   +1 more source

LDL-C goal achievement rates among patients with dyslipidemia (based on the 2015 Korean guidelines).

, 2020
LDL-C, low-density lipoprotein cholesterol.
Siin Kim (3949709), Yi Qian (466487), Pratik P. Rane (8378820), Sola Han (6532826), Hae Sun Suh (7249091), Zhongyun Zhao (5326046)   +5 more
core   +1 more source

PCSK9: A Key Target for the Treatment of Cardiovascular Disease (CVD) [PDF]

Advanced Pharmaceutical Bulletin, 2020
Proprotein convertase subtilisin/kexin type 9 (PCSK9), as a vital modulator of low-density lipoprotein cholesterol (LDL-C) , is raised in hepatocytes and released into plasma where it binds to LDL receptors (LDLR), leading to their cleavage.
Saeideh Sobati, Amir Shakouri, Mahdi Edalati, Daryoush Mohammadnejad, Reza Parvan, Javad Masoumi, Jalal Abdolalizadeh   +6 more
doaj   +1 more source

LDL-C goal achievement rates based on the 2015 Korean guidelines and LDL-C distributions categorized by the use of lipid-modifying treatment.

, 2020
LDL-C, low-density lipoprotein cholesterol; LMT, lipid-modifying treatment.
Siin Kim (3949709), Yi Qian (466487), Pratik P. Rane (8378820), Sola Han (6532826), Hae Sun Suh (7249091), Zhongyun Zhao (5326046)   +5 more
core   +1 more source